Borron has shown 62% and 64% survival in patients with blood cyanide concentration over 100 mmol/L (2.6 mg/L), a level usually regarded as fatal, when treated with hydroxycobalamin for cyanide toxicity due to smoke inhalation and other causes , respectively.